Drug Shortage Report for TEVA-PREDNISOLONE
| Report ID | 96724 |
| Drug Identification Number | 00700401 |
| Brand name | TEVA-PREDNISOLONE |
| Common or Proper name | PREDNISOLONE |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | PREDNISOLONE ACETATE |
| Strength(s) | 1% |
| Dosage form(s) | SUSPENSION |
| Route of administration | OPHTHALMIC |
| Packaging size | 5ML |
| ATC code | S01BA |
| ATC description | ANTIINFLAMMATORY AGENTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-10-16 |
| Estimated end date | 2020-05-31 |
| Actual end date | 2020-05-20 |
| Shortage status | Resolved |
| Updated date | 2020-05-21 |
| Company comments | Allocating to 100% of our market. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2019-10-17 | English | Compare |